Manufacturing For Oral Solid Dose Success

Adare Pharma Solutions is a global, technology-driven Contract Development and Manufacturing Organization (CDMO) specializing in oral solid dosage forms. With integrated services spanning from early drug development to commercial manufacturing and packaging, Adare supports pharmaceutical companies in bringing complex small molecule products to market efficiently. Operating seven facilities across the U.S. and Europe, Adare offers a secure and scalable global network for formulation, tech transfer, and supply chain integration.

As experts in oral solid dose technologies, Adare provides patient-centric solutions for tablets, capsules, multiparticulates, and Minitabs™, with specialized platforms for taste masking, customized drug release, solubility enhancement, and ease-of-swallowing. Their integrated CDMO model streamlines the development-to-market journey through unified project management, robust quality systems, and customer-focused support.

Adare’s state-of-the-art facilities offer capabilities including dry and wet granulation, fluid bed processing, tableting, encapsulation, film coating, and comprehensive packaging formats such as bottles, blisters, and stick packs. Their seamless scale-up and tech transfer approach incorporates manufacturing input early in development, ensuring smooth transitions and cost-effective commercialization.

With a portfolio of over 65 marketed products and capabilities to manage controlled substances and complex regulatory environments, Adare stands out as a top-tier oral dose partner. Their harmonized global quality model ensures consistency and compliance across sites.

Ultimately, Adare’s combination of technical expertise, manufacturing excellence, and collaborative culture enables pharmaceutical companies to navigate challenges, optimize formulations, and deliver high-quality products that improve therapeutic outcomes for patients worldwide.